Regulatory
Fresenius Kabi Recalls a Lot of Its Arthritis Biosimilar Tyenne Over Glass Particles
The nationwide recall covers one lot of Tyenne (tocilizumab-aazg) injection after glass particles were found in the vials, a risk of irritation or vein inflammation.